Robert Hendel, MD, discussed everything from declining reimbursements in cardiology to prior authorization policies in an exclusive new interview. 

The new radiotracer flurpiridaz is poised to make a major impact on nuclear cardiology. Timothy Bateman, MD, co-director of the cardiovascular radiologic imaging program at Saint Luke's Mid America Heart Institute, shared details on the tracer in a new interview. 

Mark Rabbat, MD, discusses the Society of Cardiovascular Computed Tomography's efforts to make an impact by lobbying in Washington. 

Researchers noted that patients appeared to have myocarditis at first, but a closer examination revealed it was something else entirely. 

Cardiologist Martha Gulati, MD, lead author of the 2021 chest pain guidelines, explained how the document may have contributed to the rise of cardiac CT. "These guidelines have made it harder for people to push back and say you don't need this test," she said. 

ASNC President President Mouaz Al-Mallah, MD, said nuclear cardiology needs to upgrade old imaging systems and embrace new technology to deliver better value for patients. 

Strain imaging has gained considerable momentum in recent years as an effective tool for getting more value out of heart evaluations. Ritu Thamman, MD, provided an in-depth look at the latest trends in strain echocardiography in an exclusive interview. 

"I think everyone would agree that the current fee-for-service model is not working appropriately and there needs to be a fix," regulatory consultant Denise Garris explained in a new interview.